COVID antivirals not related to rebound or worse outcomes --study

COVID antivirals not tied to rebound or worse outcomes Rates of COVID-19 rebound were similar in patients who did and didn't receive antiviral drugs, and relapse wasn't tied to worse clinical outcomes. CIDRAP

Rates of COVID-19 rebound were similar among hospitalized patients infected with the Omicron BA.2.2 variant who did and didn't receive oral antiviral drugs, and relapse wasn't tied to worse clinical outcomes, suggests a study published yesterday in The Lancet Infectious Diseases.